- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 08.01. | Bristol Myers Squibb shares positive phase 3 results for Sotyktu in psoriatic arthritis | ||
| 08.01. | MHRA approves Italfarmaco's Duvyzat to treat Duchenne muscular dystrophy | ||
| 08.01. | Axsome announces positive results from phase 3 Alzheimer's disease programme | ||
| 07.01. | Sanofi and SK bioscience expand pneumococcal vaccine collaboration | ||
| 07.01. | Prostate cancer blood test with 'unprecedented accuracy' cuts biopsies by 50% | ||
| 07.01. | Publicis Health appoints Annabelle Sandeman as chief growth officer in UK | ||
| 06.01. | Roche gains rights to Innovent's ADC candidate in deal worth over $1bn | ||
| 06.01. | Bristol Myers Squibb's injectable Opdivo formulation granted FDA approval | ||
| 06.01. | J&J expands atopic dermatitis pipeline with Kaken Pharmaceutical licensing deal | ||
| 03.01. | Amgen's Imdyllytra approved by MHRA to treat small cell lung cancer in adults | ||
| 03.01. | BeiGene's Tevimbra combination granted FDA approval to treat gastric cancer | ||
| 03.01. | Novartis' investigational spinal muscular atrophy gene therapy shows promise in late-stage study | ||
| 02.01. | J&J's Rybrevant/Lazcluze combination approved by EC for EGFR-mutated lung cancer | ||
| 02.01. | Merck's Winrevair granted MHRA approval to treat pulmonary arterial hypertension | ||
| 23.12.24 | Pfizer's Braftovi regimen receives FDA accelerated approval to treat colorectal cancer | ||
| 23.12.24 | AstraZeneca's Tagrisso granted EC approval in EGFR-mutated lung cancer | ||
| 23.12.24 | Launching a novel drug treatment in Japan | ||
| 23.12.24 | The importance of caregivers in the patient journey | ||
| 20.12.24 | Novo Nordisk invests $1.2bn to establish rare disease production facility in Denmark | ||
| 20.12.24 | Gilead's seladelpar recommended by CHMP to treat primary biliary cholangitis | ||
| 20.12.24 | Taking the campaign against cancer into the cloud | ||
| 20.12.24 | Shaping tomorrow with strategic foresight in early commercialisation | ||
| 20.12.24 | Brand strategy - reviewing what you've learnt | ||
| 19.12.24 | Merck gains rights to Hansoh's preclinical GLP-1 candidate in deal worth $2bn | ||
| 19.12.24 | Amgen's Blincyto granted MHRA approval for new acute lymphoblastic leukaemia indication |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
